协同纳米配方:简化一合成增强帕克利塔克塞尔功能化 黄金纳米粒子具有强大的抗癌活性
Kamini Velhal1, Parvindar M Sah2, Harshala S Naik2
1Amity Institute of Biotechnology, Amity University Maharashtra, Mumbai-Pune Expressway, Bhatan, Panvel, Mumbai, Maharashtra, 410206, India.
Cell biochemistry and biophysics
|February 26, 2025
概括
这项研究开发了环保的黄金纳米颗粒,与帕克利塔塞尔功能化,用于癌症治疗. 这些纳米颗粒显示出强大的抗癌作用,特别是对结肠癌细胞,提供了一个有希望的新治疗策略.
科学领域:
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 开发用于合成功能纳米颗粒的新,可持续的方法对于推进癌症治疗是必不可少的.
- 帕克利塔克塞尔是广泛使用的化疗药物,但其输送和疗效可以得到改善.
研究的目的:
- 开发一种单一的,环保的合成帕克利塔塞尔功能化黄金纳米粒子 (PTX-AuNPs).
- 评估PTX-AuNPs对人类宫癌 (SiHa) 和人类结肠癌 (HT-29) 细胞系的抗癌疗效.
- 为了阐明帕克利塔塞尔与β-图布林结合的抗癌机制.
主要方法:
- 使用帕克利塔塞尔作为降解剂和稳定剂的PTX-AuNPs的一 in situ合成.
- 使用紫外可见光谱,XRD,FTIR,FEG-TEM和HPLC进行表征.
- 在实验室对SiHa和HT-29细胞系进行抗癌活性评估.
- 分子对接研究以确定与β-Tubulin的结合亲和力.
主要成果:
- 成功合成并对PTX-AuNPs进行表征.
- PTX-AuNPs对两种细胞系都表现出显著的抗癌活性,对HT-29细胞具有更高的效力.
- 观察到对HT-29细胞生长的剂量依赖抑制.
- 分子对接证实了帕克利塔塞尔与β-图布林 (-8.5kcal/mol) 的强烈结合亲和力.
结论:
- PTX-AuNPs的经济高效和绿色合成是癌症治疗的可行方法.
- PTX-AuNPs对增强癌症治疗,特别是结肠癌的治疗充满希望.
- 这项研究提供了关于帕克利塔克塞尔通过β-图布林相互作用的抗癌作用的机制性见解.
相关概念视频
Combined Effects of Drugs: Synergism
6.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.4K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


